INS and type 1 diabetes mellitus: Among the retrospective studies published (Table 1), three of them assessed patients exclusively with type 1 diabetes (T1D) and included patients who used insulin pumps or MDI as methods of treatment and either CGM or FGM as glycemic monitoring methods [18,19,20].